Annual Cash & Cash Equivalents
$1.01B$429.57M+73.43%
Summary
- Current Value
- As of today, GRFS annual cash & cash equivalents is $1.01B, up +73.43% on
- Historical Performance
- GRFS annual cash & cash equivalents is up +36.10% over the past 3 years, and down -63.24% over the past 5 years
- All-Time High Comparison
- GRFS annual cash & cash equivalents is currently -63.24% below its historical high of $2.76B set on
- 3-Year Low Comparison
- GRFS annual cash & cash equivalents is +73.48% above its 3-year low of $584.83M reached on an earlier date
- Sector Comparison
- GRFS annual cash & cash equivalents is higher than 93.56% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $1.01B | +73.4% | +36.1% | -63.2% | +174.9% | |
| Quarterly Cash & Cash Equivalents | $729.63M | +1.4% | +57.8% | -39.8% | – | |
| Price | $9.49 | +24.9% | +6.4% | -51.6% | – | |
| Annual Current Assets | $5.93B | -12.4% | -5.3% | -1.5% | +311.5% | |
| Annual Total Liabilities | $13.25B | -11.0% | -2.7% | +35.9% | +758.0% | |
| Annual Working Capital | $3.70B | -12.0% | +59.7% | -17.6% | +265.3% | |
| Annual Net Income | $230.19M | +30.1% | -26.6% | -68.3% | +12.2% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.01B | at high | |
| 5Y | $1.01B | at high | |
| All | $2.76B | -63.2% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $584.83M | N/A | +73.5% |
| 5Y | $584.83M | +73.5% | |
| All | $8.61M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of GRFS?
As of today, GRFS annual cash & cash equivalents is $1.01B
What is 1-year change in GRFS annual cash & cash equivalents?
GRFS annual cash & cash equivalents is up +73.43% year-over-year
What is 3-year change in GRFS annual cash & cash equivalents?
GRFS annual cash & cash equivalents is up +36.10% over the past 3 years
How far is GRFS annual cash & cash equivalents from its all-time high?
GRFS annual cash & cash equivalents is currently -63.24% below its historical high of $2.76B set on December 31, 2019
How does GRFS annual cash & cash equivalents rank versus sector peers?
GRFS annual cash & cash equivalents is higher than 93.56% of companies in Healthcare sector
When is GRFS next annual earnings release?
The next annual earnings release for GRFS is on
Quarterly Cash & Cash Equivalents
$729.63M$73.81M+11.25%
Summary
- Current Value
- As of today, GRFS quarterly cash & cash equivalents is $729.63M, up +11.25% on
- Historical Performance
- GRFS quarterly cash & cash equivalents is up +1.37% year-over-year, and up +57.77% over the past 3 years
- All-Time High Comparison
- GRFS quarterly cash & cash equivalents is currently -73.56% below its historical high of $2.76B set on
- 3-Year Low Comparison
- GRFS quarterly cash & cash equivalents is +57.77% above its 3-year low of $462.45M reached on
- Sector Comparison
- GRFS quarterly cash & cash equivalents is higher than 89.93% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $729.63M | +11.3% | +1.4% | +57.8% | -39.8% | |
| Annual Cash & Cash Equivalents | $1.01B | – | +73.4% | +36.1% | -63.2% | |
| Price | $9.49 | 0.0% | +24.9% | +6.4% | -51.6% | |
| Quarterly Current Assets | $6.28B | +2.0% | +5.8% | +22.9% | +47.1% | |
| Quarterly Total Liabilities | $14.46B | +1.4% | +5.4% | +1.0% | +44.4% | |
| Quarterly Working Capital | $3.75B | -1.8% | +13.3% | +29.5% | +33.4% | |
| Quarterly Net Income | $167.60M | +6.8% | +86.1% | +1118.3% | -49.8% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.01B | N/A | -28.1% |
| 3Y | $2.26B | -67.8% | |
| 5Y | $2.26B | -67.8% | |
| All | $2.76B | -73.6% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $655.82M | +11.3% | |
| 3Y | $462.45M | +57.8% | |
| 5Y | $447.77M | +63.0% | |
| All | $18.14M | +3922.8% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of GRFS?
As of today, GRFS quarterly cash & cash equivalents is $729.63M
What is GRFS quarterly cash & cash equivalents most recent change?
GRFS quarterly cash & cash equivalents was up +11.25% on September 1, 2025
What is 1-year change in GRFS quarterly cash & cash equivalents?
GRFS quarterly cash & cash equivalents is up +1.37% year-over-year
How far is GRFS quarterly cash & cash equivalents from its all-time high?
GRFS quarterly cash & cash equivalents is currently -73.56% below its historical high of $2.76B set on December 31, 2019
How does GRFS quarterly cash & cash equivalents rank versus sector peers?
GRFS quarterly cash & cash equivalents is higher than 89.93% of companies in Healthcare sector
When is GRFS next earnings release?
The next earnings release for GRFS is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GRFS Official Website www.grifols.com
- GRFS Profile on Yahoo Finance finance.yahoo.com/quote/GRFS
- GRFS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grfs